🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 13 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
29/12/2015 37,81 39,44 37,71 39,12 +4,13% 4,58% 920.500
28/12/2015 38,31 38,49 37,05 37,57 -2,29% 3,76% 700.600
24/12/2015 38,35 38,97 38,15 38,45 +0,03% 2,14% 298.900
23/12/2015 37,48 38,50 37,25 38,44 +3,28% 3,34% 648.400
22/12/2015 37,92 38,20 36,75 37,22 -1,66% 3,82% 693.900
21/12/2015 38,02 38,14 37,20 37,85 +0,83% 2,47% 1.026.400
18/12/2015 35,61 38,85 35,33 37,54 +4,77% 9,88% 2.346.500
17/12/2015 38,20 38,24 35,13 35,83 -3,68% 8,14% 1.184.000
16/12/2015 36,80 37,45 35,87 37,20 +1,72% 4,29% 1.177.800
15/12/2015 35,38 36,88 35,28 36,57 +4,52% 4,52% 796.600
14/12/2015 35,04 35,90 33,91 34,99 -0,77% 5,68% 1.175.600
11/12/2015 36,64 36,90 35,13 35,26 -4,75% 4,83% 997.300
10/12/2015 36,34 37,13 35,68 37,02 +1,68% 3,99% 570.300
09/12/2015 36,79 37,00 35,86 36,41 -1,06% 3,10% 648.200
08/12/2015 35,29 37,00 35,00 36,80 +3,05% 5,67% 986.200
07/12/2015 37,00 37,10 34,84 35,71 -3,62% 6,11% 1.164.600
04/12/2015 36,45 37,11 35,73 37,05 +2,12% 3,79% 1.086.500
03/12/2015 37,06 37,67 35,66 36,28 -2,45% 5,42% 1.088.900
02/12/2015 36,72 38,09 36,46 37,19 +0,73% 4,44% 1.083.100
01/12/2015 36,78 37,15 35,93 36,92 +0,44% 3,32% 1.127.200
30/11/2015 37,77 38,38 36,00 36,76 -1,71% 6,30% 1.900.300
27/11/2015 37,49 38,19 37,04 37,40 -0,24% 3,07% 1.007.500
25/11/2015 37,13 39,35 36,60 37,49 +0,46% 7,41% 3.568.400
24/11/2015 37,35 38,09 34,78 37,32 +0,73% 8,86% 4.810.200
23/11/2015 35,16 38,08 34,00 37,05 +11,06% 11,60% 5.108.100
20/11/2015 31,86 34,96 31,33 33,36 +27,96% 11,39% 10.213.400
19/11/2015 27,85 28,20 25,10 26,07 -5,95% 11,13% 1.941.800
18/11/2015 27,27 29,12 27,12 27,72 +1,54% 7,33% 2.317.500
17/11/2015 26,74 27,80 26,19 27,30 +5,24% 6,02% 1.877.500
16/11/2015 25,60 26,14 24,93 25,94 +0,43% 4,73% 988.600